The Alpha-1 Foundation is committed to finding a cure for Alpha 1 Antitrypsin Deficiency and to improving the lives of people affected by Alpha 1 worldwide.
Alpha 1 Antitrypsin Deficiency
Alpha 1 Antitrypsin Deficiency
-
1 in 1,500 - 3,500
incidence of severe Alpha 1 in people of European descent
-
20 - 40 yrs. old
typical occurrence of first signs and symptoms
-
116 million
estimated carriers of abnormal Alpha 1 genes worldwide
How is Alpha 1 Diagnosed?
Alpha 1 can only be diagnosed by a blood test. If you have a family history of Alpha 1, COPD, emphysema, irreversible asthma, unexplained liver disease, or a skin disorder called necrotizing panniculitis, you should be tested. Alpha 1 is a progressive disease, which means if it is left undiagnosed and untreated, it can get worse and may do more harm to your lungs and body over time.
Alpha 1 Fast Facts
Check out this infographic for five key messages from the Alpha-1 Foundation, including important info about how easy it is to get tested.
See InfographicTips for Those Newly Diagnosed with Alpha 1
Feelings of isolation can be common among people diagnosed with a rare disease. But Dee Kroecker, who is living with the rare genetic condition Alpha 1 Antitrypsin Deficiency, wants newly diagnosed patients to know that they are not alone.
Watch Dee's TipsHow Alpha 1 Antitrypsin Works - The Liver/Lung Connection
Alpha 1 Antitrypsin (AAT) is a protein made in your liver. Its main function is to protect your lungs against attack by an enzyme called neutrophil elastase which is usually involved in the inflammation caused by infection and inhaled irritants such as tobacco smoke. With respect to AATD, a low level of AAT in the blood occurs because the AAT is abnormal and cannot be released from the liver at the normal rate. This leads to an accumulation of abnormal AAT in the liver that can cause liver disease and a decrease of AAT in the blood that can lead to lung disease.